Adverse drug-drug interaction (ADDI) is a significant life-threatening issue, posing a leading cause of hospitalizations and deaths in healthcare systems. This paper proposes a unified Multi-Attribute Discriminative Representation Learning (MADRL) model for ADDI prediction. Unlike the existing works that equally treat features of each attribute without discrimination and do not consider the underlying relationship among drugs, we first develop a regularized optimization problem based on CUR matrix decomposition for joint representative drug and discriminative feature selection such that the selected drugs and features can well approximate the original feature spaces and the critical factors discriminative to ADDIs can be properly explored. Different from the existing models that ignore the consistent and unique properties among attributes, a Generative Adversarial Network (GAN) framework is then designed to capture the inter-attribute shared and intra-attribute specific representations of adverse drug pairs for exploiting their consensus and complementary information in ADDI prediction. Meanwhile, MADRL is compatible with any kind of attributes and capable of exploring their respective effects on ADDI prediction. An iterative algorithm based on the alternating direction method of multipliers is developed for optimization. Experiments on publicly available dataset demonstrate the effectiveness of MADRL when compared with eleven baselines and its six variants.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/TPAMI.2021.3135841 | DOI Listing |
Am J Perinatol
December 2024
Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.
Objective: We aimed to evaluate the relationship between intrapartum continuous glucose monitoring (CGM) and neonatal hypoglycemia (NH) in individuals with diabetes.
Study Design: a multicenter prospective study (November 2021-December 2022) of laboring individuals with pregestational or gestational diabetes at ≥34 weeks. Cohorts had a blinded CGM placed from admission through delivery and were monitored with fingerstick (FS) according to usual care.
Tunis Med
October 2024
Washington DC VA Medical Center, Department of Pathology, 20422, Washington, DC, USA.
Introduction: Granular cell tumors (GCT) are predominantly benign neoplasms composed by cells with abundant eosinophilic granular cytoplasm. Although the majority of GCTs exhibit a benign clinical course, a minority display cytological atypia and may exhibit aggressive, cancer-like behavior. Definitive evidence of malignancy in GCTs is reliably established only through the presence of metastasis.
View Article and Find Full Text PDFSaudi Pharm J
October 2024
School of Electronic Engineering, Kyonggi University, Yeongtong-gu, Suwon, Gyeonggi-do 16227, Republic of Korea.
Sci Rep
August 2024
Department of Critical Care Medicine, South Shore Hospital, 55 Fogg Road, South Weymouth, MA, 02190, USA.
Low muscle mass is associated with numerous adverse outcomes independent of other associated comorbid diseases. We aimed to predict and understand an individual's risk for developing low muscle mass using proteomics and machine learning. We identified eight biomarkers associated with low pectoralis muscle area (PMA).
View Article and Find Full Text PDFAlzheimers Dement
September 2024
Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centre, Vrije Universiteit, Amsterdam, The Netherlands.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!